Forget forex trading: I think the AstraZeneca share price offers an easier way to get rich

AstraZeneca plc (LON: AZN) could offer a superior risk/reward ratio than forex trading in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

Forex trading has become increasingly popular in recent years. Investors seem to be attracted by the potential to make quick profits betting on currencies that can quickly change direction.

The risk of loss is, of course, relatively high. That’s partly why it may be a better idea to buy shares in a growth stock such as AstraZeneca (LSE: AZN). It appears to offer an improving financial outlook, while also trading on a fair valuation and having defensive characteristics.

Alongside another growth share that released an encouraging update on Thursday, AstraZeneca may offer a better chance of generating high long-term returns than forex trading.

Should you invest £1,000 in JD Sports right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if JD Sports made the list?

See the 6 stocks

Growth potential

The stock in question is budget hotel operator easyHotel (LSE: EZH). Its trading update for the first six months of its financial year showed a rise in system sales of 24% to £19.9m, while revenue increased by 47% to £7m. Its hotels outperformed the wider UK market, with consumer confidence coming under pressure. But this may suit the business, since its budget offering could prove popular among consumers who are looking to trade down to cheaper options.

The company’s actions to drive occupancy appear to be having a positive impact on its performance. It is also seeking to capitalise on economic weakness in order to expand its development pipeline in target destinations.

Looking ahead, easyHotel is expected to post a rise in earnings of 300% in the current year. It trades on a price-to-earnings growth (PEG) ratio of 0.2, which suggests that it offers excellent value for money. While potentially risky due in part to its small size, it could offer high returns in the long run.

Changing business

Although AstraZeneca may not be considered a growth stock by many investors due to its disappointing performance over recent years, the investment it has made in its pipeline has led to a changed business. In recent quarters it has reported improving growth, with its bottom line due to rise by around 13% in the current year. This suggests that the challenges it has faced in recent years in terms of the loss of patents on blockbuster drugs are beginning to fade.

As a result, now could be a good time to buy the stock. It trades on a PEG ratio of 1.7, which indicates that it offers a wide margin of safety. That’s especially the case since the company has a defensive business model that is relatively independent of the wider economy when it comes to delivering growth. And, with it having strong cash flow, its pipeline investment could increase over the medium term.

Certainly, trading forex may sound more exciting than buying shares in a healthcare company such as AstraZeneca. But with the world’s population growing and ageing, the company could have a real growth opportunity, while its stable balance sheet and resilient growth prospects mean that its risks may be significantly lower than those experienced when trading forex.

Passive income stocks: our picks

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

National Grid engineers at a substation
Investing Articles

National Grid shares: a £1,000 investment 5 years ago is now worth…

National Grid shares are on the rise! Here’s how much money investors have made so far… and how much they…

Read more »

Close-up of children holding a planet at the beach
Investing Articles

Vodafone shares: a £1,000 investment 5 years ago is now worth…

Vodafone shares have underwhelmed since 2020, but could the stock be on the verge of an explosive comeback? Here's what…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

Investing £1,000 in BT shares 5 years ago: here’s how much could have been made…

BT shares are on the rise as the company steers itself towards £2bn of free cash flow generation by March…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

£100,000 invested in Tesco shares at the start of 2025 is now worth…

Tesco shares are on the rise as the UK's leading supermarket continues to dominate, but how much money have investors…

Read more »

Abstract 3d arrows with rocket
Investing Articles

This UK growth share turned £1,000 into £5,000!

Contrary to popular belief, there are some phenomenal UK growth shares capable of delivering game-changing returns just waiting to be…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

£10,000 invested in Scottish Mortgage shares 3 years ago is now worth…

Scottish Mortgage shares reflect the value of their holdings, and over the past three years the trust has performed rather…

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

Will these FTSE 100 shares surge or sink in July?

Our writer Royston Wild looks at three popular FTSE shares and runs the rule over their near-term share price prospects.

Read more »

Young Black man sat in front of laptop while wearing headphones
Investing Articles

3 reasons I’m avoiding Lloyds shares despite their huge dividends!

Lloyds shares offer some of the most reliable dividend yields on the FTSE 100. But our writer Royston Wild still…

Read more »